PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Alcohol consumption has no impact on breast cancer survival

However, breast cancer survivors who consume alcohol in moderation may have a reduced risk of dying from heart disease

2013-04-09
(Press-News.org) SEATTLE – Although previous research has linked alcohol consumption to an increased risk of developing breast cancer, a new study has found that drinking before and after diagnosis does not impact survival from the disease. In fact, a modest survival benefit was found in women who were moderate drinkers before and after diagnosis due to a reduced risk of dying from cardiovascular disease, a major cause of mortality among breast cancer survivors. The study results will be published in the April 8 edition of the Journal of Clinical Oncology. Polly Newcomb, Ph.D., a member of the Public Health Sciences Division and head of the Cancer Prevention Program at Fred Hutchinson Cancer Research Center, led the study. "Our findings should be reassuring to women who have breast cancer because their past experience consuming alcohol will not impact their survival after diagnosis," said Newcomb. "This study also provides additional support for the beneficial effect of moderate alcohol consumption with respect to cardiovascular disease." The study was based on data from almost 23,000 women who participated in the Collaborative Breast Cancer Study, a National Cancer Institute-sponsored, multi-site, population-based study of risk factors for breast cancer. The study began in 1988 and was conducted in New Hampshire, Massachusetts and Wisconsin. In a smaller follow-up study between 1998 and 2001, about 5,000 participants were sent a follow-up questionnaire about their alcohol consumption habits after diagnosis. Among study participants with a history of breast cancer, the authors found that the amount and type of alcohol a woman reported consuming in the years before her diagnosis was not associated with her likelihood from dying from breast cancer. However, the authors also found that those who consumed a moderate level of alcohol (three to six drinks per week) in the years before their cancer diagnosis were 15 percent less likely to die from cardiovascular disease than non-drinkers. Moderate wine consumption in particular was associated with a lower risk of cardiovascular disease mortality, while no such benefit was evident for consumption of beer or spirits, or for heavier levels of alcohol consumption. Similar patterns were evident when considering reported alcohol consumption after breast cancer diagnosis. The amount and type of alcohol a woman consumed after diagnosis did not appear to be associated with survival of breast cancer, but those who consumed alcohol in moderation experienced a 39- to 50-percent lower mortality rate from cardiovascular disease. What could account for the difference in alcohol's impact on developing breast cancer risk and on survival from the disease? "It could be that the kind of breast cancer that is more likely to be diagnosed among women who drink may be more responsive to hormone-reduction therapies," Newcomb said. Alcohol consumption is believed to influence breast cancer risk through increases in estrogen production in both pre- and post-menopausal women. ### Funding for the study was provided by grants from the National Cancer Institute and Komen for the Cure. Co-authors included researchers from the University of Wisconsin Paul B. Carbone Comprehensive Cancer Center, Wageningen University in the Netherlands, H. Lee Moffitt Cancer Center, Norris Cotton Cancer Center, the University of North Carolina Lineberger Cancer Center and Research Institute, and Harvard Medical School and Brigham and Women's Hospital. Editor's note: Please contact Dean Forbes in Fred Hutch media relations to request interviews with Newcomb. Please contact the journal - mediateam@asco.org – to obtain an embargoed copy of the Journal of Clinical Oncology paper, "Alcohol Consumption Before and After Breast Cancer Diagnosis: Associations with Survival From Breast Cancer; Cardiovascular Disease and Other Causes."

About Fred Hutchinson Cancer Research Center

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch's pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation's first and largest cancer prevention research program, as well as the clinical coordinating center of the Women's Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit http://www.fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.

CONTACT Dean Forbes END


ELSE PRESS RELEASES FROM THIS DATE:

Canada loses out on drug pricing: UBC study

2013-04-09
Health systems worldwide are increasingly negotiating secret price rebates from pharmaceutical companies and Canadians risk losing out on the deal. "The pricing of medicines is now a game of negotiation, similar to buying a car at a dealership," says Steve Morgan, an expert in health policy at the University of British Columbia. "There's a list price equivalent to a manufacturer's suggested retail price; and then there's secret deals that everyone negotiates from there." In a study published today in the April issue of the journal Health Affairs, researchers interviewed ...

Strict school meal standards associated with improved weight status among students

2013-04-09
A study suggests that states with stricter school meal nutrition standards were associated with better weight status among students who received free or reduced-price lunches compared with students who did not eat school lunches, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication. The National School Lunch Program (NSLP) was started in 1946 to improve student nutrition by providing school lunches according to standards sets by the U.S. Department of Agriculture (USDA). However, the program has faced criticism that the lunches did ...

Pre-pregnancy body fat, in-pregnancy weight gain, and gestational diabetes combine to increase risk of high birthweight babies to differing degrees in white, black, Hispanic, and Asian women

2013-04-09
A new study shows that a woman's pre-pregnancy body fat (adiposity), in-pregnancy weight gain, and presence of gestational diabetes mellitus (GDM) can all combine to steeply increase the risk of giving birth to large-for-gestational age (LGA) babies to different degrees in white non-Hispanic, black non-Hispanic, White Hispanic, and Asian women, with the highest combined risk being in White non-Hispanic women. The research is published in the journal Diabetologia (the journal of the European Association for the Study of Diabetes) and is led by Dr Katherine Bowers and Dr ...

Environmental change triggers rapid evolution

2013-04-09
A University of Leeds-led study, published in the journal Ecology Letters, overturns the common assumption that evolution only occurs gradually over hundreds or thousands of years. Instead, researchers found significant genetically transmitted changes in laboratory populations of soil mites in just 15 generations, leading to a doubling of the age at which the mites reached adulthood and large changes in population size. The results have important implications in areas such as disease and pest control, conservation and fisheries management because they demonstrate that ...

Adding intestinal enzyme to diets of mice appears to prevent, treat metabolic syndrome

2013-04-09
Feeding an intestinal enzyme to mice kept on a high-fat diet appears to prevent the development of metabolic syndrome – a group of symptoms associated with type 2 diabetes, cardiovascular disease and fatty liver – and to reduce symptoms in mice that already had the condition. In their report published online in PNAS Early Edition, Massachusetts General Hospital (MGH) investigators describe how dietary supplementation with intestinal alkaline phosphatase (IAP) reduced the inflammation believed to underlie metabolic syndrome by blocking a toxic molecule found on the surface ...

Nearly half of breast cancer patients at risk of having BRCA mutations not sent for genetic testing

2013-04-09
WASHINGTON, DC -- Only 53 percent of newly diagnosed breast cancer patients who were at high risk of carrying a BRCA 1 or BRCA 2 mutation – based on age, diagnosis, and family history of breast or ovarian cancer – reported that their doctors urged them to be tested for the genes, according to a research team from the Perelman School of Medicine at the University of Pennsylvania. The findings, which will be presented during the American Association for Cancer Research Annual Meeting 2013 (Presentation #1358), were drawn from surveys completed by 2,258 women between 18 ...

Adding cetuximab to chemotherapy enables select patients with advanced colorectal cancer and liver metastasis to undergo surgery, extending survival by several months

2013-04-09
In this News Digest: Summary of a study being published online April 8, 2013 in the Journal of Clinical Oncology, reports that adding cetuximab (Erbitux) to chemotherapy enabled previously inoperable patients to undergo surgery, tripling the rates of successful surgery for liver metastasis. The combination of cetuximab and chemotherapy extended median overall survival for this population of patients by 10 months compared with chemotherapy alone. Quote for attribution to Neal Meropol, MD, American Society of Clinical Oncology Cancer Communications Committee member ...

Month of birth impacts on immune system development

2013-04-09
Newborn babies' immune system development and levels of vitamin D have been found to vary according to their month of birth, according to new research. The research, from scientists at Queen Mary, University of London and the University of Oxford, provides a potential biological basis as to why an individual's risk of developing the neurological condition multiple sclerosis (MS) is influenced by their month of birth. It also supports the need for further research into the potential benefits of vitamin D supplementation during pregnancy. Around 100,000 people in the ...

Study finds key to calling back-up help when tumor-fighter p53 goes down

2013-04-09
WASHINGTON, D.C. – Tumor suppression, the family business of the sibling genes p53, p63 and p73, is undermined from within by the split personalities of p63 and p73, which each produce protein forms that not only block the work of the other two genes but also shut down its own cancer-stifling fraternal twin. In a presentation at the AACR Annual Meeting 2013, scientists from The University of Texas MD Anderson Cancer Center demonstrate that tumor suppression can be restored in mice that lack p53 by knocking out the ∆N isoforms of p63 and p73 that interfere with tumor ...

AACR news: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants

2013-04-09
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013. "With molecularly targeted agents, we typically see 3 or 4 CRC explant models with a significant decrease in tumor growth. Here we have a drug that was active in every explant we tested. It's really exciting," says John Arcaroli, PhD, investigator at the University ...

LAST 30 PRESS RELEASES:

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

A surgical handover system for patient physiology and safety

Cardiovascular health changes in young adults and risk of later-life cardiovascular disease

Nurse workload and missed nursing care in neonatal intensive care units

How to solve the remote work stalemate – dissertation offers tools for successful hybrid work

Chip-based phonon splitter brings hybrid quantum networks closer to reality

Texas Children’s researchers create groundbreaking tool to improve accuracy of genetic testing

Milken Institute, Ann Theodore Foundation announce more than $2.5 million in new funding for sarcoidosis research and launch new call for proposals

Boston University professor to receive 2025 Eugene Braunwald Academic Mentorship Award

[Press-News.org] Alcohol consumption has no impact on breast cancer survival
However, breast cancer survivors who consume alcohol in moderation may have a reduced risk of dying from heart disease